Czech blood plasma saga leads to treaty claim
The Czech Republic is facing a billion-dollar investment treaty claim arising from a two-decade dispute with a blood plasma supplier whose efforts to enforce a US$650 million award against the state have been repeatedly thwarted.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10